APTO Message Board Post 9472442 | Aptose Biosciences Inc.
home / stock / apto / apto message board
Harkd
(investorshub)
Posted on: Apr/14/2023 20:25:10
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171690547
Chance to be used after Gilteritinib? Sure. It
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO, TSX:APS), a clinical- stage precision oncology com...
-
SAN DIEGO and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended...
-
Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML Tuspetinib Continues Broad Activity Across Mutations with Excellent Safety Profile Luxeptinib G3 Formulation Achieves Desired Levels and Positions for Future Trials Conference Call ...